Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M846Revenue $M45.9Net Margin (%)-47.2Altman Z-Score15.2
Enterprise Value $M650EPS $-0.4Operating Margin %-49.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-48.6Higher ROA y-yY
Price/Book4.110-y EBITDA Growth Rate %-2.7Quick Ratio10.2Cash flow > EarningsY
Price/Sales16.55-y EBITDA Growth Rate %-4.7Current Ratio10.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-9.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-11.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M69.5ROIC % (ttm)-110.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJoel Greenblatt 2015-03-31 Sold Out -0.0021%$12.64 - $18.54
($15.47)
$ 12.17-21%Sold Out0
SGMOJoel Greenblatt 2014-12-31 Buy $9.85 - $16.53
($12.15)
$ 12.170%New holding17,441
SGMOFirst Eagle Investment 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 12.17-15%Add 34.10%536,380
SGMOFirst Eagle Investment 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 12.17-36%Reduce 52.81%400,000
SGMOFirst Eagle Investment 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 12.1722%Add 99.73%847,550
SGMOFirst Eagle Investment 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 12.1740%Add 41.45%424,350
SGMOFirst Eagle Investment 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 12.1737%New holding300,000
SGMOFirst Eagle Investment 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 12.17116%Sold Out0
SGMOFirst Eagle Investment 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 12.17107%New holding470
SGMOFirst Eagle Investment 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 12.1793%Sold Out0
SGMOFirst Eagle Investment 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 12.17190%New holding260,600
SGMOFirst Eagle Investment 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 12.17197%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-05-15Sell25,000$11.515.73view
Wolff Henry WardExec VP & CFO 2015-05-11Sell12,000$13.25-8.15view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-05-05Sell15,000$12.29-0.98view
RINGO WILLIAM RDirector 2015-05-04Sell3,000$12.98-6.24view
Gregory Philip DSVP of Research & CSO 2015-05-01Sell15,000$12.62-3.57view
LANPHIER EDWARD O IIPresident & CEO 2015-04-15Sell25,000$15.33-20.61view
Wolff Henry WardExec VP & CFO 2015-04-10Sell12,000$15.31-20.51view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-04-06Sell15,000$14.94-18.54view
RINGO WILLIAM RDirector 2015-04-06Sell2,200$14.95-18.6view
Gregory Philip DSVP of Research & CSO 2015-04-01Sell15,000$15.15-19.67view

Press Releases about SGMO :

    Quarterly/Annual Reports about SGMO:

    News about SGMO:

    Articles On GuruFocus.com
    Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 

    More From Other Websites
    Sangamo BioSciences Presents New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storge... May 18 2015
    Sangamo BioSciences Presents New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storge... May 18 2015
    Sangamo BioSciences Provides Clinical Update On SB-728-T Program and Developments In Other ZFP... May 14 2015
    Sangamo BioSciences Provides Clinical Update On SB-728-T Program and Developments In Other ZFP... May 14 2015
    Sangamo BioSciences Announces Joint Steering Committee Decision To Consolidate ZFP Therapeutic®... May 13 2015
    Sangamo BioSciences Announces Joint Steering Committee Decision To Consolidate ZFP Therapeutic®... May 13 2015
    Sangamo BioSciences Announces Presentation At The UBS 2015 Global Healthcare Conference May 12 2015
    Sangamo BioSciences Announces Presentation At The UBS 2015 Global Healthcare Conference May 12 2015
    Sangamo BioSciences Announces Presentation At The Bank Of America Merrill Lynch 2015 Health Care... May 07 2015
    10-Q for Sangamo BioSciences, Inc. Apr 30 2015
    Sangamo BioSciences And Collaborators To Present Data On ZFP Therapeutic Applications At Annual... Apr 29 2015
    Gene Therapy Stocks Take Beating On Bad News For Celladon Apr 27 2015
    First experiment 'editing' human embryos ignites ethical furor Apr 23 2015
    First experiment 'editing' human embryos ignites ethical furor Apr 23 2015
    First experiment 'editing' human embryos ignites ethical furor Apr 23 2015
    Street Talk: SKX, FFIV, STJ, TCBI & SGMO Apr 23 2015
    Sangamo BioSciences Inc Earnings Call scheduled for 5:00 pm ET today Apr 22 2015
    Sangamo reports 1Q loss Apr 22 2015
    Sangamo reports 1Q loss Apr 22 2015
    SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK